Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BABA-W
09988
5
JD HEALTH
06618
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.02%127.6M | 8.83%31.88M | 6.04%33.47M | 5.46%32.27M | -3.95%29.97M | -7.83%122.66M | -11.58%29.3M | -0.55%31.56M | -9.73%30.6M | -9.06%31.2M |
| Cost of revenue | 7.73%78.22M | 11.20%19.48M | 16.04%21.43M | 1.05%19.57M | 2.80%17.74M | -15.14%72.61M | -8.08%17.51M | -16.12%18.46M | -2.47%19.37M | -29.94%17.26M |
| Gross profit | -1.35%49.38M | 5.31%12.41M | -8.05%12.04M | 13.05%12.7M | -12.30%12.23M | 5.34%50.06M | -16.32%11.78M | 34.70%13.1M | -19.99%11.24M | 44.09%13.94M |
| Operating expense | 642.64%19.84M | 119.01%3.69M | 123.99%4.96M | -72.16%5.51M | 14.40%6.29M | -73.62%2.67M | -373.03%-19.42M | -820.51%-20.66M | 229.25%19.78M | 85.99%5.49M |
| Selling and administrative expenses | -5.03%22.73M | 23.08%6.44M | 4.28%4.61M | -54.41%5.48M | 28.48%6.2M | 11.47%23.93M | -21.34%5.23M | -10.17%4.42M | 129.36%12.02M | 57.37%4.83M |
| -General and administrative expense | -5.03%22.73M | 23.08%6.44M | 4.28%4.61M | -54.41%5.48M | 28.48%6.2M | 11.47%23.93M | -21.34%5.23M | -10.17%4.42M | 129.36%12.02M | 57.37%4.83M |
| Other operating expenses | -78.57%1.46M | ---- | --1.55M | -99.66%26K | -87.69%82K | 328.11%6.81M | ---- | ---- | 912.66%7.76M | --666K |
| Total other operating income | -84.49%4.35M | -88.84%2.75M | -95.21%1.2M | ---- | ---- | 147.45%28.07M | --24.65M | 1,123.67%25.07M | ---- | -98.25%2K |
| Operating profit | -37.65%29.54M | -72.06%8.72M | -79.01%7.09M | 184.22%7.2M | -29.66%5.94M | 26.72%47.39M | 347.72%31.2M | 392.39%33.75M | -206.32%-8.54M | 25.69%8.45M |
| Net non-operating interest income (expenses) | 31.06%-3.33M | 67.39%-196K | 27.48%-966K | 20.63%-1.05M | 29.00%-1.11M | 40.46%-4.82M | 62.44%-601K | 38.62%-1.33M | 40.53%-1.33M | 25.51%-1.56M |
| Non-operating interest income | 7.54%756K | 36.23%188K | 87.70%229K | -25.00%201K | -21.14%138K | 189.30%703K | 176.00%138K | 2,340.00%122K | 824.14%268K | 10.06%175K |
| Non-operating interest expense | -26.15%4.08M | -48.04%384K | -17.81%1.2M | -21.37%1.26M | -28.21%1.25M | 267.42%5.53M | -55.21%739K | -33.15%1.45M | -29.44%1.6M | -23.01%1.74M |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | -25.95%5.06M | ---- | ---- | ---- | ---- |
| Net investment income | -831.87%-666K | |||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -98.34%2.8M | 93.61%788K | -114.29%-10K | -98.66%2.02M | 9,933.33%602K | 28,718.97%168.59M | -89.61%407K | -88.64%70K | 150.64M | -99.78%6K |
| Less:Other special charges | ---- | ---- | ---- | ---- | -9,933.33%-602K | -3,455.47%-171.09M | ---- | 33.60%-409K | ---150.64M | 99.78%-6K |
| Less:Write off | -212.05%-2.8M | -93.61%-788K | -97.05%10K | ---2.02M | ---- | 527.01%2.5M | -13.69%-407K | --339K | --0 | ---- |
| Other non-operating income (expenses) | 7,424.33%150.64M | |||||||||
| Income before tax | -86.26%29.02M | -69.97%9.31M | -81.19%6.11M | -94.20%8.16M | -21.13%5.44M | 606.70%211.15M | 233.94%31M | 512.92%32.49M | 1,703.77%140.77M | -7.96%6.89M |
| Income tax | -127.63%-15.7M | -419.14%-18.62M | -99.86%7K | -95.37%2.13M | 783K | 818.44%56.82M | -2.81%5.84M | 2,562.30%4.87M | 46.12M | 0 |
| Net income | -71.03%44.72M | 10.98%27.93M | -77.90%6.1M | -93.63%6.03M | -32.49%4.65M | 551.40%154.33M | 667.32%25.17M | 439.64%27.62M | 1,112.83%94.65M | -7.96%6.89M |
| Net income continuous operations | -71.03%44.72M | 10.98%27.93M | -77.90%6.1M | -93.63%6.03M | -32.49%4.65M | 551.40%154.33M | 667.32%25.17M | 439.64%27.62M | 1,112.83%94.65M | -7.96%6.89M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -71.03%44.72M | 10.98%27.93M | -77.90%6.1M | -93.63%6.03M | -32.49%4.65M | 551.40%154.33M | 667.32%25.17M | 439.64%27.62M | 1,112.83%94.65M | -7.96%6.89M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -71.03%44.72M | 10.98%27.93M | -77.90%6.1M | -93.63%6.03M | -32.49%4.65M | 551.40%154.33M | 667.32%25.17M | 439.64%27.62M | 1,112.83%94.65M | -7.96%6.89M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -79.51%0.0337 | 11.05%0.0211 | -77.88%0.0046 | -93.70%0.0045 | -73.08%0.0035 | 268.01%0.1645 | 206.45%0.019 | 116.67%0.0208 | 385.71%0.0714 | -7.80%0.013 |
| Diluted earnings per share | -79.51%0.0334 | 10.58%0.0209 | -77.78%0.0046 | -93.69%0.0045 | -73.08%0.0035 | 264.65%0.163 | 204.84%0.0189 | 115.63%0.0207 | 385.48%0.0714 | -7.80%0.013 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.